Embio is a leading player in the domain of controlled substances. It is world's largest fully integrated manufacturers of API and its advanced intermediates.
Über die Pflanze
Technology and innovation is the backbone of Embio’s success, which allows us to achieve a leadership position as a manufacturer of Active Pharmaceutical Ingredients (APIs), Intermediates and Speciality chemicals catering to a range of global customers in the pharmaceutical, nutraceutical, food, cosmetic, crop & plant protection segments. With 35+ years of experience in handling bacterial, fungal & Category 1 GMO bio-transformation, Embio has demonstrated an impeccable track record in creating sustainable, environmental friendly and disruptive technologies. With licenses to manufacture Schedule-1 & Schedule-2 substances, Embio is a leading global player in the domain of controlled substances, advanced intermediates & chiral molecules. Embio’s State of the Art manufacturing facility is approved by US-FDA, PMDA, KFDA, COFEPRIS, ANVISA & WHO-GMP. Our products & services cater to the stringent requirements of a large customer base in more than 80 countries, with a major share from regulated markets that includes originator and large multi-national companies.